Agilent Technologies Inc

US

AX

Health Care

133.91 ₽

Current price

Sell
133.91 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    99 / 240

  • Position in country

    6451 / 14179

  • Return on Assets, %

    11.4

    -2.7

  • Net income margin, %

    20.9

    -6.7

  • EBITDA margin, %

    27

    5.6

  • Debt to Equity, %

    41.2

    15.1

  • Intangible assets and goodwill, %

    40.2

    4.7

  • Revenue CAGR 3Y, %

    8.5

    12.8

  • Total Equity change 1Y, %

    10.3

    -2.4

  • Revenue Y, % chg

    -2.9

    0

  • P/E

    33.6

    32.1

  • P/BV

    6.6

    2

  • P/S

    6.1

    4.1

  • EV/S

    6.2

    3.6

  • EV/EBITDA

    21.9

    7.8

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    6.5

    48.9

  • Forward P/E

    24.4

    25.5

  • Dividend Yield, %

    0.6

    0.8

  • Forward Dividend Yield, %

    0.7

    0.2

  • Expected dividend per share

    1

    0

  • Payout Ratio, %

    21.6

    10.1

  • Dividend Ex Date

    2024-04-01

Get an analytical review of this company

Competitors

Ranks

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Avantor Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Revvity Inc

    00%

  • Illumina Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    41241.6

  • Ticker

    A.N

  • ISIN

    US00846U1016

  • IPO date

    1999-11-18

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-03-05

  • Date fact. publication of reports

    2024-01-31

Company Description

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.